The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia
Abstract
In the past decades, a lot of effort has been put in identifying the role of matrix metalloproteinases (MMPs) in cancer. The main role of MMPs in angiogenesis, tumor growth and metastasis is degradation of extracellular matrix (ECM) and release and/or activation of growth factors through their degradative activity. The degradative activity finally results in cancer progression. MMP-inhibitors (MMPIs) have already been designed and tested, based on the degradative role of MMPs in cancer progression. First clinical trials with MMPIs have been performed with disappointing results, showing that in order to use MMP-inhibition the mechanisms underlying MMP-expression in cancer have to be further elucidated. This paper reviews the mechanisms of MMPs on molecular and cellular level and discusses the role for MMPs and MMP-inhibition in cancer with special focus on acute leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959 · cited 5×
“Four TIMPs (TIMP-1–4) have been identified so far [7,8,17,23,28,43,44] .”
BackgroundInfluentialCell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915 · cited 1×
“v 3-integrin is localized to focal adhesion sites and promotes cell spreading and migration on various RGD-motif containing substrates [62,65,77] .”
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Role of angiogenesis in tumor growth and metastasis
Folkman, J. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37263 · Cited by 2,404
Role of angiogenesis in tumor growth and metastasis
FOLKMAN, J. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70065-1 · Cited by 2,400
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
Borregaard, N., & Cowland, J. B. (1997) · Blood · doi:10.1182/blood.v89.10.3503 · Cited by 1,522
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5
Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., & Quaranta, V. (1997) · Science · doi:10.1126/science.277.5323.225 · Cited by 1,221 · cited 2×
“[96] Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V.”
BackgroundProcessing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
The insulin-like growth factor system and cancer
LeRoith, D., & Roberts, C. T. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00159-9 · Cited by 1,124
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Matrix metalloproteinases in tumor invasion and metastasis
Stamenkovic, I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0379 · Cited by 815
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
Springman, E. B., Angleton, E. L., Birkedal-Hansen, H., & Van Wart, H. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.364 · Cited by 713
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
Liotta, L. A., & Stetler‐Stevenson, W. G. (1991) · PubMed · Cited by 705
Schönbeck, U., Mach, F., & Libby, P. (1998) · PubMed · Cited by 681
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E., Thomas, D., Koller, C., Estrov, Z., O'Brien, S., Keating, M., et al. (2000) · Blood · doi:10.1182/blood.v96.6.2240 · Cited by 680
Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Eliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649
Matrix metalloproteinases: multifunctional contributors to tumor progression
McCawley, L. J., & Matrisian, L. M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01686-5 · Cited by 643
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Vihinen, P., & Kähäri, V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10329 · Cited by 637
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
Duffy, M. J., Maguire, T. M., Hill, A., McDermott, E., & O'Higgins, N. (2000) · Breast Cancer Research · doi:10.1186/bcr65 · Cited by 628
TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knäuper, V., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01031-x · Cited by 609
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
John, A., & Tuszynski, G. (2001) · Pathology & Oncology Research · doi:10.1007/bf03032599 · Cited by 609
Whitelock, J. M., Murdoch, A. D., Iozzo, R. V., & Underwood, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10079 · Cited by 597
Schönbeck, U., Mach, F., & Libby, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3340 · Cited by 595
Will, H., Atkinson, S. J., Butler, G. S., Smith, B., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17119 · Cited by 569
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.
Pérez‐Atayde, A. R., Sallan, S. E., Tedrow, U. B., Connors, S. L., Allred, E. N., & Folkman, J. (1997) · Europe PMC (PubMed Central) · Cited by 553
Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism Revealed
Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., & Tryggvason, K. (1999) · Science · doi:10.1126/science.284.5420.1667 · Cited by 540
Curran, S., & Murray, G. I. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00156-8 · Cited by 531
Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., & Kalluri, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730882100 · Cited by 488
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M. (2000) · Blood · doi:10.1182/blood.v95.8.2637 · Cited by 476
Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth
Kamphaus, G. D., Colorado, P. C., Panka, D. J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J. W., Sukhatme, V. P., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1209 · Cited by 475
Molecular mechanisms of blood vessel formation
Bussolino, F., Mantovani, A., & Persico, G. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01074-8 · Cited by 470
IMAI, K., HIRAMATSU, A., FUKUSHIMA, D., PIERSCHBACHER, M. D., & OKADA, Y. (1997) · Biochemical Journal · doi:10.1042/bj3220809 · Cited by 445
Anti-angiogenic cues from vascular basement membrane collagen.
Colorado, P. C., Torre, A., Kamphaus, G. D., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E. D., Herman, S., Sarkar, P. K., et al. (2000) · PubMed · Cited by 426
Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.
DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E., & Taylor, S. M. (1992) · PubMed · Cited by 423
Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., & Mignatti, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2319 · Cited by 422
Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo
Wang, Z., Juttermann, R., & Soloway, P. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001270200 · Cited by 390
Bernhard, E. J., Gruber, S. B., & Muschel, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4293 · Cited by 385
Coussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 384
Ye, S. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00102-5 · Cited by 380
(2008) · doi:10.1016/b978-1-4160-3703-3.x5001-7 · Cited by 373
Seftor, R. E. B., Seftor, E. A., Koshikawa, N., Meltzer, P. S., Gardner, L. M. G., Bilban, M., Stetler‐Stevenson, W. G., Quaranta, V., & Hendrix, M. J. C. (2001) · PubMed · Cited by 369
Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane
Maeshima, Y., Colorado, P. C., Torre, A., Holthaus, K. A., Grunkemeyer, J. A., Ericksen, M. B., Hopfer, H., Xiao, Y., Stillman, I. E., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001956200 · Cited by 358
Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A., & Vlodavsky, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7069 · Cited by 351
Kim, Y. M., Jang, J.-W., Lee, O., Yeon, J.-H., Choi, E.-Y., Kim, K., Lee, S., & Kwon, Y. (2000) · PubMed · Cited by 347
Tumor necrosis factor-α converting enzyme
Black, R. A. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00097-8 · Cited by 346
Schmalfeldt, B., Prechtel, D., Härting, K., Späthe, K., Rutke, S., Konik, E., Fridman, R., Berger, U., Schmitt, M., Kuhn, W. C., et al. (2001) · PubMed · Cited by 334
Suzuki, M., Raab, G., Moses, M. A., Fernandez, C. A., & Klagsbrun, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31730 · Cited by 330
Tumor Cell Invasion Inhibited by TIMP-2
Albini, A., Melchiori, A., Santi, L., Liotta, L. A., Brown, P. D., & Stetler-Stevenson, W. G. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.775 · Cited by 321
Structure of the human type IV collagenase gene.
Huhtala, P., Chow, L. T., & Tryggvason, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38559-x · Cited by 310
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
Storgard, C. M., Stupack, D. G., Jonczyk, A., Goodman, S. L., Fox, R. I., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3756 · Cited by 310
Human endothelial gelatinases and angiogenesis
Nguyen, M. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00007-3 · Cited by 300
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10868 · Cited by 292
Kinoshita, T., Sato, H., Okada, A., Ohuchi, E., Imai, K., Okada, Y., & Seiki, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16098 · Cited by 281
Zucker, S., Drews, M., Conner, C., Foda, H. D., DeClerck, Y. A., Langley, K. E., Bahou, W. F., Docherty, A. J. P., & Cao, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.1216 · Cited by 281
Bian, J., & Sun, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6330 · Cited by 276
Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., & Albini, A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<246::aid-ijc13>3.0.co;2-b · Cited by 273
O'Reilly, M. S., Wiederschain, D., Stetler-Stevenson, W. G., Folkman, J., & Moses, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29568 · Cited by 272
Qin, H., Sun, Y., & Benveniste, E. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29130 · Cited by 271
Discoidin domain receptors: structural relations and functional implications
Vogel, W. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9001.s77 · Cited by 269
Steps in tumor metastasis: new concepts from intravital videomicroscopy
Chambers, A. F., MacDonald, I. C., Schmidt, E. E., Koop, S., Morris, V. L., Khokha, R., & Groom, A. C. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690599 · Cited by 265
Silletti, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011343298 · Cited by 262
Karsdal, M. A., Larsen, L., Engsig, M. T., Lou, H., Ferreras, M., Lochter, A., Delaissé, J.-M., & Foged, N. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207205200 · Cited by 250
Malignant glioma biology: Role for TGF-? in growth, motility, angiogenesis, and immune escape
Platten, M., Wick, W., & Weller, M. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<401::aid-jemt1025>3.0.co;2-c · Cited by 242
Hohlbaum, A. M., Moe, S., & Marshak-Rothstein, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1209 · Cited by 241
Barberá‐Guillem, E., Nyhus, J. K., Wolford, C. C., Friece, C., & Sampsel, J. W. (2002) · PubMed · Cited by 233
Integrin and ECM functions: roles in vertebrate development
De Arcangelis, A. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02074-6 · Cited by 231
Molecular genetics of vascular malformations
Vikkula, M., Boon, L. M., & Mulliken, J. B. (2001) · Matrix Biology · doi:10.1016/s0945-053x(01)00150-0 · Cited by 228
Endogenous angiogenesis inhibitors and their therapeutic implications
Cao, Y. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00023-1 · Cited by 228
Borregaard, N., Sehested, M., Nielsen, B., Sengelov, H., & Kjeldsen, L. (1995) · Blood · doi:10.1182/blood.v85.3.812.bloodjournal853812 · Cited by 227
Morgunova, E., Tuuttila, A., Bergmann, U., & Tryggvason, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102185399 · Cited by 219
Deryugina, E. I., Ratnikov, B. I., Postnova, T. I., Rozanov, D. V., & Strongin, A. Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110269200 · Cited by 212
Janowska-Wieczorek, A., Marquez, L. A., Nabholtz, J.-M., Cabuhat, M. L., Montaño, J., Chang, H., Rozmus, J., Russell, J. A., Edwards, D. R., & Turner, A. R. (1999) · Blood · doi:10.1182/blood.v93.10.3379.410k09_3379_3390 · Cited by 207
Fridman, R., Fuerst, T. R., Bird, R. E., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta, L. A., Berman, M. L., & Stetler-Stevenson, W. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49547-1 · Cited by 200
The role of collagen-derived proteolytic fragments in angiogenesis
Marneros, A. G., & Olsen, B. R. (2001) · Matrix Biology · doi:10.1016/s0945-053x(01)00151-2 · Cited by 199
Bernhard, E. J., Muschel, R. J., & Hughes, E. N. (1990) · PubMed · Cited by 196
de Paulsen, N., Brychzy, A., Fournier, M.-C., Klausner, R. D., Gnarra, J. R., Pause, A., & Lee, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1387 · Cited by 187
Davidson, B., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Ben-Baruch, G., Nesland, J. M., Berner, A., Bryne, M., & Reich, R. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006723011835 · Cited by 183
Cellular Activation of MMP-2 (Gelatinase A) by MT2-MMP Occurs via a TIMP-2-independent Pathway
Morrison, C. J., Butler, G. S., Bigg, H. F., Roberts, C. R., Soloway, P. D., & Overall, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108643200 · Cited by 180
Janowska-Wieczorek, A., Marquez, L. A., Dobrowsky, A., Ratajczak, M. Z., & Cabuhat, M. L. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00532-4 · Cited by 173
Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.
Koop, S., MacDonald, I. C., Luzzi, K. J., Schmidt, E. E., Morris, V. L., Grattan, M., Khokha, R., Chambers, A. F., & Groom, A. C. (1995) · PubMed · Cited by 173
Ongoing trials with matrix metalloproteinase inhibitors
Brown, P. D. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.9.2167 · Cited by 167
Kataki, A., Scheid, P., Piet, M., Marie, B., Martinet, N., Martinet, Y., & Vignaud, J.-M. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.128317 · Cited by 166
Thrailkill, K. M., Quarles, L. D., Nagase, H., Suzuki, K., SERRA, D. M., & Fowlkes, J. L. (1995) · Endocrinology · doi:10.1210/en.136.8.3527 · Cited by 163
Lokeshwar, B. L., Selzer, M. G., Zhu, B., Block, N. L., & Golub, L. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10168 · Cited by 161
Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., & Groom, A. C. (1994) · PubMed · Cited by 157
Biological implications of macrophage infiltration in human tumor angiogenesis
Ono, M., Torisu, H., Fukushi, J.-I., Nishie, A., & Kuwano, M. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051101 · Cited by 157
Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives
Hoekstra, R., Eskens, F. A. L. M., & Verweij, J. (2001) · The Oncologist · doi:10.1634/theoncologist.6-5-415 · Cited by 154
Ohta, M., Kitadai, Y., Tanaka, S., Yoshihara, M., Yasui, W., Mukaida, N., Haruma, K., & Chayama, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10705 · Cited by 153
Mast Cell Expression of Gelatinases A and B Is Regulated by kit Ligand and TGF-β
Fang, K. C., Wolters, P. J., Steinhoff, M. S., Bidgol, A., Blount, J. L., & Caughey, G. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5528 · Cited by 144
Tonn, J., Kerkau, S., Hanke, A., Bouterfa, H., Mueller, J. G., Wagner, S., Vince, G. H., & Roosen, K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990301)80:5<764::aid-ijc22>3.0.co;2-j · Cited by 142
Lafleur, M. A., Hollenberg, M. D., Atkinson, S. J., Knäuper, V., Murphy, G., & Edwards, D. R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570107 · Cited by 140
Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases
Fowlkes, J. L., Thrailkill, K. M., Serra, D. M., Suzuki, K., & Nagase, H. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00017-8 · Cited by 138
Price, A., Shi, Q., Morris, D., Wilcox, M. E., Brasher, P. M. A., Rewcastle, N. B., Shalinsky, D. R., Zou, H. Y., Appelt, K., Johnston, R. N., et al. (1999) · PubMed · Cited by 137
Angiogenesis in hematologic malignancies
Moehler, T. M., Ho, A. D., Goldschmidt, H., & Barlogie, B. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00135-x · Cited by 136
Khokha, R., Zimmer, M. J., Graham, C. H., Lala, P. K., & Waterhouse, P. D. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.13.1017 · Cited by 135
DeClerck, Y. A., Yean, T. D., Chan, D. Y., Shimada, H., & Langley, K. E. (1991) · PubMed · Cited by 134
Hofmann, U. B., Westphal, J. R., van Kraats, A. A., Ruiter, D. J., & van Muijen, G. N. P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000701)87:1<12::aid-ijc3>3.0.co;2-a · Cited by 132
Morris, V. L., MacDonald, I. C., Koop, S., Schmidt, E. E., Chambers, A. F., & Groom, A. C. (1993) · Clinical & Experimental Metastasis · doi:10.1007/bf00132981 · Cited by 129
Membrane-type metalloproteinases in tumor invasion
Polette, M., & Birembaut, P. L. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00083-1 · Cited by 129
Brandstetter, H., Grams, F., Glitz, D., Lang, A., Huber, R., Bode, W., Krell, H., & Engh, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007475200 · Cited by 129
Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta.
Fang, K. C., Wolters, P. J., Steinhoff, M. S., et al. (1999) · PubMed · Cited by 126
Adamalysins: A Family of Metzincins Including TNF‐α Converting Enzyme (TACE)
Killar, L. M., White, J. M., Black, R. A., & Peschon, J. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07701.x · Cited by 126
Increased gelatinase-A and gelatinase-B activities in malignantvs. benign breast tumors
Hanemaaijer, R., Verheijen, J. H., Maguire, T. M., Visser, H., Toet, K. H., McDermott, E. W. M., O’Higgins, N. J., & Duffy, M. J. (2000) · International Journal of Cancer · Cited by 118
Endostatin binds to the catalytic domain of matrix metalloproteinase‐2
Lee, S., Jang, J.-W., Kim, Y.-M., Lee, H. I., Jeon, J. Y., Kwon, Y., & Lee, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02742-4 · Cited by 116
Target molecules for anti-angiogenic therapy: from basic research to clinical trials
Hagedorn, M., & Bikfalvi, A. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00056-1 · Cited by 116
Herbst, R. S., Yano, S., Kuniyasu, H., Khuri, F. R., Bucana, C. D., Guo, F., Liu, D., Kemp, B. L., Lee, J. J., Hong, W. K., et al. (2000) · PubMed · Cited by 116
Bello, L., Lucini, V., Carrabba, G. G., Giussani, C. G., Machluf, M., Pluderi, M., Nikas, D. L., Zhang, J., Tomei, G., Villani, R. M., et al. (2001) · PubMed · Cited by 115
Cao, J. P., Rehemtulla, A., Bahou, W. F., & Zucker, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.30174 · Cited by 114
de Bont, E. S. J. M., Rosati, S., Jacobs, S. C., Kamps, W. A., & Vellenga, E. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02722.x · Cited by 111
Self-citationWallon, U. M., & Overall, C. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7473 · Cited by 108
Mertens, P. R., Alfonso-Jaume, M., Steinmann, K., & Lovett, D. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32957 · Cited by 108
Janowska‐Wieczorek, A., Marquez‐Curtis, L. A., Matsuzaki, A., Hashmi, H., Larratt, L. M., Boshkov, L., Turner, A. R., Zhang, M., Edwards, D. R., & Kossakowska, A. E. (1999) · British Journal of Haematology · doi:10.1111/j.1365-2141.1999.01352.x · Cited by 107
Steitz, J., Br�ck, J., Steinbrink, K., Enk, A., Knop, J. X. F. R., & Tüting, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<15::aid-ijc3>3.0.co;2-b · Cited by 106
Feldman, A. L., Tamarkin, L., Paciotti, G. F., Simpson, B. W., Linehan, W. M., Yang, J. C., Fogler, W. E., Turner, E. M., Alexander, H. R., & Libutti, S. K. (2000) · PubMed · Cited by 104
Shedding of membrane proteins by ADAM family proteases
Moss, M. L., & Lambert, M. H. (2002) · Essays in Biochemistry · doi:10.1042/bse0380141 · Cited by 99
Domain Interactions in the Gelatinase A·TIMP-2·MT1-MMP Activation Complex
Overall, C. M., Tam, E. M., McQuibban, G. A., Morrison, C., Wallon, U. M., Bigg, H. F., King, A. E., & Roberts, C. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005932200 · Cited by 99
Chambers, A. F., Schmidt, E. E., MacDonald, I. C., Morris, V. L., & Groom, A. C. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.10.797 · Cited by 95
Vacca, A., Ria, R., Presta, M., Ribatti, D., Iurlaro, M., Merchionne, F., Tanghetti, E., & Dammacco, F. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00674-9 · Cited by 89
The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma.
Stack, M. S., Ellerbroek, S. M., & Fishman, D. A. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.3.569 · Cited by 87
Overall, C. M., King, A. E., Sam, D. K., Ong, A., Lau, T. T. Y., Wallon, U. M., DeClerck, Y. A., & Atherstone, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4421 · Cited by 84
MT-MMPs play pivotal roles in cancer dissemination
Yana, I., & Seiki, M. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015527220537 · Cited by 82
de Paulsen, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031587498 · Cited by 78
Timpl, R., Paulsson, M., Dziadek, M. A., & Fujiwara, S. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(87)45021-0 · Cited by 77
Zeng, H., Datta, K., Neid, M., Li, J., Parangi, S., & Mukhopadhyay, D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00107-4 · Cited by 68
Guan, K., Ye, H., Yan, Z., et al. (2003) · Urology · doi:10.1016/s0090-4295(02)02429-9 · Cited by 66
Effect of Matrix Metalloproteinase Inhibition on Pancreatic Cancer Invasion and Metastasis
Jimenez, R. E., Hartwig, W., Antoniu, B. A., Compton, C. C., Warshaw, A. L., & Castillo, C. F.-D. (2000) · Annals of Surgery · doi:10.1097/00000658-200005000-00004 · Cited by 66
Multiple Metalloproteinases Process Protransforming Growth Factor-α (ProTGF-α)
Hinkle, C. L., Mohan, M. J., Lin, P., Yeung, N., Rasmussen, F., Milla, M. E., & Moss, M. L. (2003) · Biochemistry · doi:10.1021/bi026709v · Cited by 64
Zervos, E. E., Norman, J. G., Gower, W. R., Franz, M., & Rosemurgy, A. S. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5086 · Cited by 64
Pulè, M. A., Gulmann, C., Dennis, D., McMahon, C., Jeffers, M. D., & Smith, O. P. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03761.x · Cited by 58
Chen, J., Baskerville, C., Han, Q., Pan, Z. K., & Huang, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107574200 · Cited by 57
Elevated serum endostatin is associated with poor outcome in patients with non‐Hodgkin lymphoma
Bono, P., Teerenhovi, L. M., & Joensuu, H. (2003) · Cancer · doi:10.1002/cncr.11399 · Cited by 57
Serum endostatin predicts tumor vascularity in hepatocellular carcinoma
Dhar, D. K., Ono, T., Yamanoi, A., Soda, Y., Yamaguchi, E., Rahman, M. A., Kohno, H., & Nagasue, N. (2002) · Cancer · doi:10.1002/cncr.10972 · Cited by 56
Marquez‐Curtis, L. A., Dobrowsky, A., Montaño, J., Turner, A. R., Ratajczak, J., Ratajczak, M. Z., & Janowska‐Wieczorek, A. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03160.x · Cited by 52
Structural and Contractile Proteins
Lauffer, M. A. (1975) · Molecular biology, biochemistry, and biophysics · doi:10.1007/978-3-642-80869-2_8 · Cited by 49
Medina, O. P., Söderlund, T., Laakkonen, L. J., Tuominen, E. K. J., Koivunen, E., & Kinnunen, P. K. J. (2001) · PubMed · Cited by 47
Tomita, T., Fujii, M., Tokumaru, Y., Imanishi, Y., Kanke, M., Yamashita, T., Ishiguro, R., Kanzaki, J., Kameyama, K., & Otani, Y. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00446-8 · Cited by 46
TGF-α antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo
Endo, S., Zeng, Q., Burke, N. A., He, Y., Melhem, M. F., Watkins, S. C., Lango, M. N., Drenning, S. D., Huang, L., & Grandis, J. R. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301315 · Cited by 42
Glenjen, N. I., Mosevoll, K. A., & Bruserud, Ø. (2002) · International Journal of Cancer · doi:10.1002/ijc.10566 · Cited by 42
Reynolds, R. K., Hu, C., & Baker, V. V. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5089 · Cited by 42
Ivanoff, A., Ivanoff, J., Hultenby, K. R., & Sundqvist, K. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006749304315 · Cited by 39
Kolodziej, S. J., Wagenknecht, T., Strickland, D. K., & Stoops, J. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202714200 · Cited by 38
Analysis of Matrix Metalloproteinase mRNAs Expressed in Hepatocellular Carcinoma Cell Lines
Kim, J.-H., Kim, T.-H., Jang, J.-W., Jang, Y. J., Lee, K., & Lee, S. (2001) · Molecules and Cells · doi:10.1016/s1016-8478(23)17059-2 · Cited by 36
Iwasaki, M., Nishikawa, A., Fujimoto, T., Akutagawa, N., Manase, K., Endo, T., Yoshida, K., Maekawa, R., Yoshioka, T., & Kudo, R. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6573 · Cited by 33
The Mechanism of Action of Angiostatin: Can You Teach an Old Dog New Tricks?
Stack, M. S., Wahl, M., Pizzo, S. V., et al. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613016 · Cited by 32
Devy, L., Hollender, P., Munaut, C., et al. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00848-6 · Cited by 25
Ghazal‐Aswad, S., Tilby, M. J., Lind, M., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008355506863 · Cited by 24
Billinghurst, R. C., O'BRIEN, K., Poole, A. R., & McIlwraith, C. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07737.x · Cited by 22
Structural and contractile proteins. Part E. Extracellular matrix.
Cunningham, L. W. (1987) · PubMed · Cited by 7
Cited by
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112260 · Cited by 556
Bauvois, B. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.001 · Cited by 543
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.12.002 · Cited by 504
Medicinal mushroom modulators of molecular targets as cancer therapeutics
Zaidman, B.-Z., Yassin, M., Mahajna, J., & Wasser, S. P. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1787-z · Cited by 434
Metadata
- Authors
- Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 50
- Issue
- 2
- Pages
- 87-100
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W1969133782
- Cited by
- 350
- References
- 173
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.